Table 1:
Patient and lesional characteristics
| Lesion Cohorta (n = 516) | Patient Cohorta (n = 120) | Median Survival (mo) | |
|---|---|---|---|
| Age | |||
| Median | 59.7 yr | ||
| Range | 31–89 yr | ||
| Sex | |||
| Male | 53 (44%) | ||
| Female | 67 (56%) | ||
| Race | |||
| Caucasian | 106 (88%) | ||
| Other | 14 (12%) | ||
| Primary pathology | |||
| NSCLCa | 175 (34%) | 47 (39%) | 11.8 |
| SCLCa | 20 (4%) | 6 (5%) | 6.8 |
| Breast | 116 (22%) | 18 (15%) | 12.3 |
| Melanoma | 123 (24%) | 24 (20%) | 13.7 |
| Renal | 51 (10%) | 11 (9%) | 8.5 |
| Colon | 13 (2.5%) | 6 (5%) | 13.0 |
| Other | 18 (3.5%) | 8 (7%) | 10.0 |
| Radiosensitiveb | 342 (66%) | 85 (71%) | 12.3 |
| Radioresistantc | 174 (34%) | 35 (29%) | 12.9 |
Note:—NSCLCa indicates non-small cell lung carcinoma; SCLCa, small cell lung carcinoma.
a
Number of patients (%), unless otherwise specified.
b
Lung, breast, colon, other.
c
Melanoma, renal.